Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 305

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Twenty years and still counting: including women as participants and studying sex and gender in biomedical research

Open access
Mazure, Carolyn M., Jones, Daniel P.·2015·BMC Women's Health

Abstract

BACKGROUND: This paper chronicles attempts in the United States over the past 20 years to fully represent women in clinical trials and ensure the study of sex and gender in biomedical research. We maintain that productive science with the aim of serving the public health requires examining the influence of sex and gender on health outcomes. DISCUSSION: This section provides a historical perspective on the changes in recommendations and requirements of both the National Institutes of Health - the world's largest single funder of biomedical research - and the U.S. Food and Drug Administration - the world's most influential regulator of drugs and medical devices - for the acceptable conduct of research as it relates to sex and gender. We also cite all reports by the U.S. Institute of Medicine and the U.S. Congress' General Accountability Office issued from 1990 to the present on the inclusion of sex and gender in research, and selected high-impact published studies that illustrate and document the paucity of, yet the need for, inclusion of females and consideration of sex and gender in research across an array of biomedical disciplines. The key message of this paper is that it has been 20 years since the first requirements to include women as well as men in clinical trials and analyze results by sex were mandated by a U.S. federal law, yet not nearly enough progress has been made. Recent signs of potential change in both policy and practice of scientific inquiry suggest much more progress may be within reach. However, awaiting a cultural shift to allow the study of sex and gender to be embraced is not seen as an effective strategy for change. Rather, specific instrumental recommendations are offered for how to include the study of sex and gender in research so as to increase our understanding and promotion of health for the benefit of all.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12905-015-0251-9

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 19

  1. Heinrich J. Women’s Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement. In: Report to Congressional Requestors. Washington, DC: United States General Accounting Office; 2001.
  2. Institute of Medicine Board on Population Health and Public Health Practice. Sex-specific reporting of scientific research: a workshop summary. In: A report by rapporteur Wizemann TM. Washington, DC: Institute of Medicine; 2012.
  3. National Institutes of Health Office of Research on Women’s Health. Moving into the future with new dimensions and strategies for women’s health research: a vision for 2020 for women’s health research — strategic plan. Bethesda, MD: National Institutes of Health; 2010.
  4. National Institutes of Health. NIH Revitalization Act of 1993. PL 103–43. Subtitle B. 1993.
  5. United States Department of Health and Human Services Food and Drug Administration. Drug development and review definitions. Silver Spring, MD; 2010.
  6. National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Washington, DC: Fed Regist. 1994;59:11146-51.
  7. United States Department of Health and Human Services Food and Drug Administration. Investigational new drug applications and new drug applications. Washington, DC: Fed Regist. 1998;68(28):6854–62.
  8. United States Department of Health and Human Services Food and Drug Administration. Investigational new drug applications; amendment to clinical hold regulations for products intended for life-threatening diseases and conditions. Final rule. Washington, DC: Fed Regist. 2000, 65(106):34963-34971.
  9. Institute of Medicine Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders. Sex differences and implications for translational neuroscience research workshop summary. In: A report by rapporteurs Pankevich D, Wizemann T, Altevogt BM. Washington, DC: Institute of Medicine; 2011.
  10. Safdar B, McGregor AJ, McKee SA, Ali A, Radulescu R, Himelfarb NT, et al. Inclusion of gender in emergency medicine research. Acad Emerg Med. 2011;18(2):e1–4.
  11. United States Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiologic Health, Office of Device Evaluation. Annual Report Fiscal Year 1994. Silver Spring, MD: Food and Drug Administration; 1994. p. 1–67.
  12. United States Department of Health and Human Services FDA. Food and Drug Administration Safety and Innovation Act of 2012. 2012.
  13. United States Department of Health and Human Services FDA. Collection, analysis, and availability of demographic subgroup data for FDA-approved medical products. Silver Spring, MD: Food and Drug Administration; 2013.
  14. United States Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The health consequences of smoking — 50 years of progress. In: A report of the surgeon general. Atlanta, GA: United States Department of Health and Human Services; 2014.
  15. Carter C, Backus J. The Society for Women’s Health Research’s perspective on balancing the sex of animals and cells in preclinical research: a new mandate for federal funding. Part 1. Washington, DC: Society for Women’s Health Research; 2014. p.1-15.
  16. United States Congress. House Office of the Legislative Counsel, Committee on Ways and Means, Committee on Energy and Commerce, Committee on Education and Labor. Compilation of Patient Protection and Affordable Care Act: as amended through November 1, 2010 including Patient Protection and Affordable Care Act health-related portions of the Health Care and Education Reconciliation Act of 2010. Washington, DC: United States Government Printing Office; 2010.
  17. New York Times Editorial. Why Science Needs Female Mice. New York, NY: The New York Times; 2015. p. 10.
  18. National Institutes of Health Office for Protection from Research Risks. Criteria for Internal Review Board: title 45. Bethesda, MD: National Institutes of Health; 1991: 46.111.
  19. Tabak LA. Seeking Comments and Suggestions on NIH-wide Strategic Plan Framework. Bethesda, MD: The NIH Office of Disease Prevention; 2015.

Cited by

See all 305

Metadata

Authors
Mazure, C. M., & Jones, D. P.
Venue
BMC Women's Health
Published
2015-10-26
Volume
15
Issue
1
Pages
94-94
ISSN
1472-6874 (ISSN-L)
OpenAlex
W2121482342
Cited by
305
References
55
FWCI
15.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Twenty years and still counting: including women as participants and studying sex and gender in biomedical research. https://app.cochat.ai/papers/10.1186/s12905-015-0251-9
The paper
Mazure, C. M., & Jones, D. P. (2015). Twenty years and still counting: including women as participants and studying sex and gender in biomedical research. BMC Women's Health. https://doi.org/10.1186/s12905-015-0251-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.